Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon R Procter

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Vaccine|March 14, 2026
The potential global health impact and net monetary benefit of programmatic use of improved influenza vaccines: a mathematical modelling studyLucy Goodfellow, Adam Soble, Stefano Malvolti, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2021
SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling studySimon R Procter, Kaja Abbas, Stefan Flasche, et al.
The Pediatric Infectious Disease Journal|November 19, 2019
Systematic Review on the Acute Cost-of-illness of Sepsis and Meningitis in Neonates and InfantsOmar Salman, Simon R Procter, Callum McGregor, et al.
Vaccine|August 26, 2023
The potential cost-effectiveness of next generation influenza vaccines in England and Wales: A modelling analysisNaomi R Waterlow, Simon R Procter, Edwin van Leeuwen, et al.
Vaccine|November 30, 2025
A systematised review of seasonal influenza case-fatality riskJohnny A N Filipe, Carlos K H Wong, Edwin van Leeuwen, et al.
Plos Computational Biology|June 14, 2021
Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methodsBronner P Gonçalves, Simon R Procter, Sam Clifford, et al.
Vaccine|November 11, 2023
Vaccine value profile for Group B streptococcusCaroline L Trotter, Mark Alderson, Ziyaad Dangor, et al.
Vaccine|August 6, 2020
A review of the costs of delivering maternal immunisation during pregnancySimon R Procter, Omar Salman, Clint Pecenka, et al.
The Lancet. Global Health|July 21, 2020
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infectionKaja Abbas, Simon R Procter, Kevin van Zandvoort, et al.
Plos Medicine|March 14, 2023
Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectivenessSimon R Procter, Bronner P Gonçalves, Proma Paul, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Vaccine|March 14, 2026
The potential global health impact and net monetary benefit of programmatic use of improved influenza vaccines: a mathematical modelling studyLucy Goodfellow, Adam Soble, Stefano Malvolti, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2021
SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling studySimon R Procter, Kaja Abbas, Stefan Flasche, et al.
The Pediatric Infectious Disease Journal|November 19, 2019
Systematic Review on the Acute Cost-of-illness of Sepsis and Meningitis in Neonates and InfantsOmar Salman, Simon R Procter, Callum McGregor, et al.
Vaccine|August 26, 2023
The potential cost-effectiveness of next generation influenza vaccines in England and Wales: A modelling analysisNaomi R Waterlow, Simon R Procter, Edwin van Leeuwen, et al.
Vaccine|November 30, 2025
A systematised review of seasonal influenza case-fatality riskJohnny A N Filipe, Carlos K H Wong, Edwin van Leeuwen, et al.
Plos Computational Biology|June 14, 2021
Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methodsBronner P Gonçalves, Simon R Procter, Sam Clifford, et al.
Vaccine|November 11, 2023
Vaccine value profile for Group B streptococcusCaroline L Trotter, Mark Alderson, Ziyaad Dangor, et al.
Vaccine|August 6, 2020
A review of the costs of delivering maternal immunisation during pregnancySimon R Procter, Omar Salman, Clint Pecenka, et al.
The Lancet. Global Health|July 21, 2020
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infectionKaja Abbas, Simon R Procter, Kevin van Zandvoort, et al.
Plos Medicine|March 14, 2023
Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectivenessSimon R Procter, Bronner P Gonçalves, Proma Paul, et al.
Pageof 4